271 related articles for article (PubMed ID: 25933218)
1. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin induces G
Chen MJ; Cheng AC; Lee MF; Hsu YC
J Cell Physiol; 2018 Jun; 233(6):4618-4625. PubMed ID: 28833099
[TBL] [Abstract][Full Text] [Related]
5. BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation.
Tang W; Xue R; Weng S; Wu J; Fang Y; Wang Y; Ji L; Hu T; Liu T; Huang X; Chen S; Shen X; Zhang S; Dong L
Int J Cancer; 2015 Mar; 136(6):E475-87. PubMed ID: 25196217
[TBL] [Abstract][Full Text] [Related]
6. Induction of cell cycle arrest via the p21, p27-cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol.
Huang Z; Wang L; Chen L; Zhang Y; Shi P
Acta Pharm; 2015 Dec; 65(4):463-71. PubMed ID: 26677902
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
Li T; Lu J; Zhong Y
J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
[TBL] [Abstract][Full Text] [Related]
10. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
12. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
14. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
[TBL] [Abstract][Full Text] [Related]
15. BIRC6 mediates imatinib resistance independently of Mcl-1.
Okumu DO; East MP; Levine M; Herring LE; Zhang R; Gilbert TSK; Litchfield DW; Zhang Y; Graves LM
PLoS One; 2017; 12(5):e0177871. PubMed ID: 28520795
[TBL] [Abstract][Full Text] [Related]
16. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
[TBL] [Abstract][Full Text] [Related]
18. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
Li X; Liang L; Huang L; Ma X; Li D; Cai S
Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.
Wang H; Li S; Luo X; Song Z; Long X; Zhu X
Oncol Rep; 2017 Apr; 37(4):2245-2251. PubMed ID: 28260087
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
